User profiles for "author:Trudie Lang"

Trudie Lang

Professor
Verified email at ndm.ox.ac.uk
Cited by 8488

Health research capacity development in low and middle income countries: reality or rhetoric? A systematic meta-narrative review of the qualitative literature

SRP Franzen, C Chandler, T Lang - BMJ open, 2017 - bmjopen.bmj.com
Objectives Locally led health research in low and middle income countries (LMICs) is critical
for overcoming global health challenges. Yet, despite over 25 years of international efforts …

[HTML][HTML] Clinical trials have gone global: is this a good thing?

T Lang, S Siribaddana - PLoS medicine, 2012 - journals.plos.org
Clinical Trials Have Gone Global: Is This a Good Thing? | PLOS Medicine Skip to main content
Advertisement PLOS Medicine Browse Current Issue Journal Archive Special Issues Collections …

[HTML][HTML] Mortality after fluid bolus in African children with severe infection

K Maitland, S Kiguli, RO Opoka, C Engoru… - … England Journal of …, 2011 - Mass Medical Soc
Background The role of fluid resuscitation in the treatment of children with shock and life-
threatening infections who live in resource-limited settings is not established. Methods We …

Advancing global health research through digital technology and sharing data

T Lang - Science, 2011 - science.org
The imperative for improving health in the world's poorest regions lies in research, yet there
is no question that low participation, a lack of trained staff, and limited opportunities for data …

[HTML][HTML] Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age

P Bejon, J Lusingu, A Olotu, A Leach… - … England Journal of …, 2008 - Mass Medical Soc
Background Plasmodium falciparum malaria is a pressing global health problem. A previous
study of the malaria vaccine RTS, S (which targets the circumsporozoite protein), given with …

Efficacy of RTS, S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and …

A Olotu, J Lusingu, A Leach, M Lievens… - The Lancet infectious …, 2011 - thelancet.com
Summary Background RTS, S/AS01E is the lead candidate malaria vaccine. We recently
showed efficacy against clinical falciparum malaria in 5–17 month old children, during an …

[HTML][HTML] Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial

J Dunning, F Sahr, A Rojek, F Gannon, G Carson… - PLoS …, 2016 - journals.plos.org
Background TKM-130803, a small interfering RNA lipid nanoparticle product, has been
developed for the treatment of Ebola virus disease (EVD), but its efficacy and safety in …

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa

T Hawkridge, TJ Scriba, S Gelderbloem… - The Journal of …, 2008 - academic.oup.com
Background. The efficacy of bacille Calmette-Guérin (BCG) may be enhanced by
heterologous vaccination strategies that boost the BCG-primed immune response. One …

[HTML][HTML] A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya

P Bejon, J Mwacharo, O Kai, T Mwangi… - PLoS clinical …, 2006 - journals.plos.org
Objective The objective was to measure the efficacy of the vaccination regimen FFM ME-
TRAP in preventing episodes of clinical malaria among children in a malaria endemic area …

[HTML][HTML] Open source clinical science for emerging infections

JW Dunning, L Merson, GGU Rohde, Z Gao… - The Lancet Infectious …, 2014 - thelancet.com
ISARIC aims to reach a global consensus behind collection of harmonised clinical data
linked with biological sampling protocols that are of value to anyone facing future outbreaks …